Trials / Completed
CompletedNCT00707187
Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Randomized, Placebo-Controlled, Double-Blind, Cross-Over Trial of the Efficacy and Safety of IC351 in Female Patients With Raynaud Phenomenon and Female Sexual Dysfunction Secondary to Systemic Sclerosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- University of Medicine and Dentistry of New Jersey · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment of several blood vessel features of scleroderma. This includes Raynaud phenomenon as well as the vaginal dryness and discomfort associated with scleroderma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cialis | 35 pills of study medication (20 mg) |
Timeline
- Start date
- 2001-07-01
- Primary completion
- 2002-07-01
- Completion
- 2002-07-01
- First posted
- 2008-06-30
- Last updated
- 2008-06-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00707187. Inclusion in this directory is not an endorsement.